Preparation and characterization of PLGA Nanoparticles containing recombinant core-NS3 Fusion protein of hepatitis C virus as a nano-vaccine candidate
Introduction: Hepatitis C virus (HCV) is one of the most serious causes of cirrhosis, liver cancer and ultimately death, worldwide. The new direct-acting drugs are not accessible for many patients around the world and progress toward new therapeutic and anaphylactic vaccines design has not been fast...
Main Authors: | S Hekmat, MM Aslani, M Shafiee Ardestani, MR Aghasadeghi, SD Siadat, SM Sadat, M Mahdavi, S Shahbazi, F Asgarhalvaee, SMM Ghahari, F Tohidi |
---|---|
Format: | Article |
Language: | English |
Published: |
Pasteur Institute of Iran
2017-05-01
|
Series: | Vaccine Research |
Subjects: | |
Online Access: | http://vacres.pasteur.ac.ir/article-1-102-en.html |
Similar Items
-
Establishment of NS3 tumor cell line expressing Hepatitis C virus Non-structural Protein 3 as valuable tool for HCV challenging in mice
by: MH Pouriayevali, et al.
Published: (2016-05-01) -
Synthesis and characterization of physicochemical and immunological properties of recombinant NS3-G2 dendrimer conjugate
by: F Javadi, et al.
Published: (2016-05-01) -
Evaluación de un péptido quimérico NS4/NS5 para la detección de anticuerpos contra VHC
by: lvonne Gómez, et al.
Published: (2001-03-01) -
Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection
by: Pooneh Rahimi, et al.
Published: (2021-01-01) -
Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil
by: de Torres Santos AP, et al.
Published: (2021-02-01)